Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
The review, which we covered previously, concluded that “oral, synthetic cannabis products with high THC-to-CBD ratios and sublingual, extracted cannabis products with comparable THC-to-CBD ratios may be associated with short-term improvements in chronic pain and increased risk for dizziness and sedation.”
Family Medicine/General Practice June 23rd 2022
MDLinx
Levothyroxine, which is the third most popular drug in the US and the main drug used to treat primary hypothyroidism, also possesses clinically significant interactions with food, beverages, and supplements that can change the safety and efficacy of thyroid-hormone replacement therapies. This review article from Pharmaceuticals reviews 925 hypothyroid patients that highlighted “disturbing” lifestyle and diet patterns.
Endocrinology, Diabetes, Metabolism June 23rd 2022
Cleveland Clinic Journal of Medicine (CCJM)
A commentary with perspective on the clinical practice implications of the Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) trial, which demonstrated short-term noninferiority of antibiotic therapy vs. surgical therapy for patients diagnosed with acute appendicitis.
Emergency Medicine June 13th 2022
We already shared the story about the financial advantage of AI being used in colonoscopies — here is a related story featuring key takeaways regarding the importance of screening in younger people, new techniques such as linked color imaging, and the non-invasive modality MRI colonography.
Family Medicine/General Practice June 13th 2022
Infectious Disease Advisor
A new study published in Virus Research found that gargling with mouth wash leads to a mild decrease in the rate of COVID-19 transmission. Several antiseptic mouth rinses have shown potential antiviral activity against SARS-CoV-2 infectivity in vitro; however, the antiseptic agent responsible for this effect was not clear until now.
Allergy & Immunology June 7th 2022
In a 7-year study of 171,000 individuals with a mean age of 56 years, these researchers elucidate the hazard ratio for death from CVD or cancer and levels of daily coffee consumption.
Cardiology June 7th 2022